Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Cancer Epidemiology|January 22, 2018
The association between recreational physical activity, sedentary time, and colorectal polyps in a population screened for colorectal cancerDarren R Brenner, Eileen Shaw, Demetra H Yannitsos, et al.European Urology Open Science|February 7, 2022
Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysisNicholas A Bosma, Matthew T Warkentin, Chun Loo Gan, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|August 16, 2003
Quantitative trait loci for lodging resistance, plant height and partial resistance to mycosphaerella blight in field pea (Pisum sativum L.)B Tar'an, T Warkentin, D J Somers, et al.Cancer Control : Journal of the Moffitt Cancer Center|February 13, 2025
Shooting for the Moon: Can We Cut Cancer Mortality in Canada By 50% By 2050?Keaton Banik, Yibing Ruan, Mariet M Stephen, et al.Current Oncology (Toronto, Ont.)|August 28, 2024
Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in AlbertaWinson Y Cheung, Chantelle Carbonell, Vishal Navani, et al.Australian and New Zealand Journal of Public Health|July 9, 2025
Cancer control measures have prevented 230,000 deaths in Australia since the mid-1980sBrigid M Lynch, Matthew T Warkentin, Melissa M Moore, et al.Breast Cancer (Tokyo, Japan)|June 16, 2026
Risk of developing subsequent primary breast cancer among non-breast cancer survivors: a retrospective cohort studyYibing Ruan, Hannah Harsanyi, Matthew T Warkentin, et al.Gastro Hep Advances|April 30, 2026
Blood Biomarkers of Glucose Metabolism and Liver Function Modestly Improve Prediction of High-Risk AdenomasR Liam Sutherland, Yibing Ruan, Matthew T Warkentin, et al.JNCI Cancer Spectrum|July 31, 2019
Factors Associated With Small Aggressive Non-Small Cell Lung Cancers in the National Lung Screening Trial: A Validation StudyMatthew T Warkentin, Martin C Tammemägi, Matthew T Freedman, et al.Chest|March 16, 2026
Integrating deep learning of low-dose computed tomography with clinical data for lung cancer risk predictionRenzo Phellan Aro, Stephen Lam, Matthew T Warkentin, et al.Pageof 5